Christopher L. VANDEUSEN,Franz J. WEIBERTH,Harpal S. GILL,George LEE,Andrea HILLEGASS
申请号：
US15258892
公开号：
US20170231990A1
申请日:
2016.09.07
申请国别(地区):
US
年份:
2017
代理人:
摘要：
This invention is directed to a compound of formula (I):wherein R1, R2 and R3 are as defined herein, a pharmaceutical composition comprising the compound, intermediates and processes for making said compounds, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma, chronic obstructive pulmonary disease (COPD) and age-related macular degeneration (AMD).
